A novel one-step synthesis of Gd3+-incorporated mesoporous SiO2 nanoparticles for use as an efficient MRI contrast agent

Contrast Media and Molecular Imaging

Volumn 6, Issue 2, 2011, Pages 110-118

  Shao, Yuan Zhi ^a   Liu, Li Zhi ^b   Song, Shu Qin ^a   Cao, Ri Hui ^a   Liu, Huan ^a   Cui, Chun Yan ^b   Li, Xing ^a   Bie, Meng Jie ^a   Li, Li ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Contrast agent; Density functional theory; Gadolinium; Magnetic resonance imaging; Nanoparticles; Silica

Indexed keywords

GADOLINIUM; GADOLINIUM PENTETATE; NANOCOATING; NANOPARTICLE; POLY(LACTIC CO GLYCOLIC ACID); SILICON DIOXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL STRUCTURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG SYNTHESIS; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; LIVER; MOLECULAR IMAGING; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TUMOR XENOGRAFT;

ANIMALS; CONTRAST MEDIA; GADOLINIUM; MAGNETIC RESONANCE IMAGING; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; SILICON DIOXIDE;

EID: 79955068094     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.412     Document Type: Article

References (22)

1. Kannie ChanaWY, Wong WT. Small molecular gadolinium(III) complexes as MRI contrast agents for diagnostic imaging. Coord Chem Rev 2007; 251: 2428-2451.
2. Weinmann HJ, Ebert W, Misselwitz B, et al. Tissue-specific MR contrast agents. Eur J Radiol 2003; 46: 33-44.
3. Morawski AM, Winter PM, Crowder KC, et al. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med 2004; 51: 480-486.
4. Weissleder R, Moore A, Mahmood-Bhorade U, et al. High resolution in vivo imaging of transgene expression. Nat Med 2000; 6: 351-355.
5. Winter PM, Caruthers SD, Yu X, et al. Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med 2003; 50: 411-416.
6. Flacke S, Fischer S, Scott MJ, et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 2001; 104: 1280-1285.
7. Sipkins DA, Cheresh DA, Kazemi MR, et al. Detection of tumor angiogenesis in vivo by alpha(v)beta(3)-targeted magnetic resonance imaging. Nat Med 1998; 4: 623-626.
8. Allen M, Bulte JW, Liepold L, et al. Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. Magn Reson Med 2005; 54: 807-812.
9. Park JA, Kim HK, Kim JH, et al. Gold nanoparticles functionalized by gadolinium-DTPA conjugate of cysteine as a multimodal bioimaging agent. Bioorg Med Chem Lett 2010; 20: 2287-2291.
10. Alric C, Taleb J, Le Duc G, et al. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. J Am Chem Soc 2007; 129: 5076-5084.
11. Taylor KML, Kim JS, Rieter WJ, et al. Mesoporous silica nanospheres as highly efficient MRI contrastagents. J Am Chem Soc 2008; 130: 2154-2155.
12. Hsiao JK, Tsai CP, Chung TH, et al. Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking. Small 2008; 4: 1445-1452.
13. Faure AC, Dufort S, Josserand V, et al. Control of the in vivo biodistribution of hybrid nanoparticles with different poly(ethylene glycol) coatings. Small 2009; 5: 2565-2575.
14. Yang J, Zeng Y, Li Y, Song C, Zhu W, Guan H, Li X. Intravascular site-specific delivery of a therapeutic antisense for the inhibition of restenosis. Eur J Pharm Sci 2008; 18; (35): 427-434.
15. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001; 219: 316-333.
16. Weissleder R, Lee AS, Khaw BA, Shen T, Brady TJ. Antimyosinlabeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. Radiology 1992; 182: 381-385.
17. Kooi ME, Cappendijk VC, Cleutjens KB, et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003; 107: 2453-2458.
18. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004; 17: 484-499.
19. Lin YS, Hung Y, Su JK, et al. Gadolinium(III)-incorporated nanosized mesoporous silica as potential magnetic resonance imaging contrast agents. J Phys Chem 2004; 108: 15608-15611.
20. Lu ZR, Parker DL, Goodrich KC, et al. Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI. Magn Reson Med 2004; 51: 27-34.
21. Fossheim SL, Kellar KE, Mansson, ???, et al. Investigation of lanthanide-based starch particles as a model system for liver contrast agents. Magn Reson Imag 1999; 9: 295-303.
22. Reynolds CH, Annan N, Beshah K, et al. Gadolinium-loaded nanoparticles: new contrast agents for magnetic resonance imaging. J Am Chem Soc 2000; 122: 8940-8945.